CHEBI:749681 - denosumab

ChEBI IDCHEBI:749681
ChEBI Namedenosumab
Stars
Last Modified29 June 2026
SubmitterChEMBL
Roles Classification
Applications:
gout suppressant  A drug that increases uric acid excretion by the kidney (uricosuric drug), decreases uric acid production (antihyperuricemic), or alleviates the pain and inflammation of acute attacks of gout.
antirheumatic drug  A drug used to treat rheumatoid arthritis.
renoprotective agent  Any compound that is able to prevent damage to the kidneys.
bone density conservation agent  An agent that inhibits bone resorption and/or favor bone mineralization and bone regeneration. Used to heal bone fractures and to treat bone diseases such as osteopenia and osteoporosis.
antineoplastic agent  A substance that inhibits or prevents the proliferation of neoplasms.
hypoglycemic agent  A drug which lowers the blood glucose level.
appetite enhancer  A drug which increases appetite.
ChEBI Ontology
Outgoing Relation(s)
denosumab (CHEBI:749681) has role antineoplastic agent (CHEBI:35610)
denosumab (CHEBI:749681) has role antirheumatic drug (CHEBI:35842)
denosumab (CHEBI:749681) has role appetite enhancer (CHEBI:50779)
denosumab (CHEBI:749681) has role bone density conservation agent (CHEBI:50646)
denosumab (CHEBI:749681) has role gout suppressant (CHEBI:35845)
denosumab (CHEBI:749681) has role hypoglycemic agent (CHEBI:35526)
denosumab (CHEBI:749681) has role renoprotective agent (CHEBI:231911)
denosumab (CHEBI:749681) is a organic molecular entity (CHEBI:50860)
Synonyms  Source
AMG 162ChEMBL
AMG-162ChEMBL
AMG162ChEMBL
Ct-p41ChEMBL
CTP-41ChEMBL
CTP41ChEMBL
Brand Names  Source
ProliaChEMBL
Prolia, ranmark xgevaChEMBL
Prolia, xgevaChEMBL
XgevaChEMBL